- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Westbrook Today
By the People, for the People
Schroder Investment Management Group Increases Stake in IDEXX Laboratories
The investment firm added over 7,500 shares of the veterinary diagnostics company in the third quarter.
Published on Mar. 10, 2026
Got story updates? Submit your updates here. ›
Schroder Investment Management Group increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.4% in the third quarter, according to a recent SEC filing. The fund now owns 323,305 shares of the company's stock, worth approximately $203.9 million.
Why it matters
IDEXX Laboratories is a leading provider of veterinary diagnostic products and services. The increase in Schroder's stake suggests the investment firm sees continued growth potential in the company, which could signal positive momentum for IDEXX's business.
The details
According to the 13F filing, Schroder Investment Management Group acquired an additional 7,520 shares of IDEXX Laboratories during the third quarter. This increased the firm's total position to 323,305 shares, or about 0.40% of the company's outstanding stock.
- Schroder Investment Management Group increased its stake in the third quarter of 2026.
The players
Schroder Investment Management Group
A global asset management firm that oversees over $1 trillion in assets.
IDEXX Laboratories, Inc.
A leading provider of veterinary diagnostic products and services, headquartered in Westbrook, Maine.
The takeaway
Schroder's increased stake in IDEXX Laboratories suggests the investment firm sees long-term growth potential in the veterinary diagnostics market, which could be a positive sign for the company's future performance.
